We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
(+13%)
Cap. Flow
+$160M
Cap. Flow
% of AUM
21.21%
Top 10 Holdings %
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dave & Buster's
PLAY
|
+$2.84M |
| 2 |
Live Nation Entertainment
LYV
|
+$2.81M |
| 3 |
Wolverine World Wide
WWW
|
+$2.72M |
| 4 |
Tesla
TSLA
|
+$2.63M |
| 5 |
CALY
Callaway Golf Company
CALY
|
+$2.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Genpact
G
|
+$3.61M |
| 2 |
Relay Therapeutics
RLAY
|
+$2.99M |
| 3 |
Extreme Networks
EXTR
|
+$2.33M |
| 4 |
Casey's General Stores
CASY
|
+$2.21M |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
+$2.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.63% |
| 2 | Consumer Discretionary | 15.71% |
| 3 | Technology | 14.34% |
| 4 | Industrials | 12% |
| 5 | Financials | 11.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
AXT Inc
AXTI
$5.8B
| $90K | 0.01% |
13,490
-17,904
| -57% | -$141K |
|
1377
Planet Labs
PL
$8.53B
| $90K | 0.01% |
+16,628
| New | +$91.8K |
|
|
GGRP
1378
Glimpse Group
GGRP
$18.7M
| $88K | 0.01% |
+16,647
| New | +$88.6K |
|
1379
BrightView Holdings
BV
$1.07B
| $87K | 0.01% |
10,920
-21,584
| -66% | -$231K |
|
|
CTLP
1380
DELISTED
Cantaloupe
CTLP
| $87K | 0.01% |
25,021
-34,285
| -58% | -$188K |
|
|
FTCH
1381
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $85K | 0.01% |
+11,381
| New | +$101K |
|
|
SLAI
1382
DELISTED
SOLAI Ltd ADS
SLAI
| $84K | 0.01% |
4,297
+3,702
| +622% | +$137K |
|
1383
Marqeta
MQ
$1.66B
| $82K | 0.01% |
2,872
-14,028
| -83% | -$467K |
|
1384
Nexa Resources
NEXA
$1.87B
| $81K | 0.01% |
+15,660
| New | +$90.4K |
|
1385
Nu Holdings
NU
$66.9B
| $81K | 0.01% |
+18,377
| New | +$84.4K |
|
|
AKTS
1386
DELISTED
Akoustis Technologies Inc
AKTS
| $81K | 0.01% |
27,411
-39,364
| -59% | -$160K |
|
|
CARM
1387
DELISTED
Carisma Therapeutics
CARM
| $80K | 0.01% |
+9,431
| New | +$128K |
|
1388
Backblaze
BLZE
$1.16B
| $79K | 0.01% |
+15,845
| New | +$95.1K |
|
1389
Xeris Biopharma Holdings
XERS
$1.45B
| $78K | 0.01% |
50,094
+5,458
| +12% | +$9.03K |
|
1390
Enviri
NVRI
$620M
| $77K | 0.01% |
20,460
+5,485
| +37% | +$30.4K |
|
|
TIGR
1391
UP Fintech Holding
TIGR
$860M
| $77K | 0.01% |
+23,423
| New | +$89.4K |
|
1392
Veritone
VERI
$122M
| $77K | 0.01% |
13,681
-101,142
| -88% | -$711K |
|
|
ADVM
1393
DELISTED
Adverum Biotechnologies
ADVM
| $75K | 0.01% |
+7,908
| New | +$104K |
|
|
AGS
1394
DELISTED
PlayAGS
AGS
| $75K | 0.01% |
+14,070
| New | +$84.7K |
|
|
ARR
1395
Armour Residential REIT
ARR
$2.36B
| $75K | 0.01% |
+3,095
| New | +$109K |
|
1396
Riskified
RSKD
$716M
| $75K | 0.01% |
+19,043
| New | +$89.3K |
|
|
SRNE
1397
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $75K | 0.01% |
47,595
+26,074
| +121% | +$59.1K |
|
1398
Rapid Micro Biosystems
RPID
$86.2M
| $74K | 0.01% |
23,055
-6,780
| -23% | -$26.3K |
|
|
SGMO
1399
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $74K | 0.01% |
15,050
-7,735
| -34% | -$39.7K |
|
|
RTL
1400
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $72K | 0.01% |
+12,289
| New | +$90.9K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q3 2022 Portfolio in Review
As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.
GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.
- GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
- GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
- GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
- GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
- GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
- GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
- GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.
Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.